CYP2E1 is a CYP-P450 enzyme that is mainly expressed in the liver, highest in hepatocytes, and has been identified as one of the relevant risk factors in NAFLD pathology [123,124,125]. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatotic liver disease.